CH600873A5 - Acylaminocarboxylic acid compsns - Google Patents
Acylaminocarboxylic acid compsnsInfo
- Publication number
- CH600873A5 CH600873A5 CH1034873A CH1034873A CH600873A5 CH 600873 A5 CH600873 A5 CH 600873A5 CH 1034873 A CH1034873 A CH 1034873A CH 1034873 A CH1034873 A CH 1034873A CH 600873 A5 CH600873 A5 CH 600873A5
- Authority
- CH
- Switzerland
- Prior art keywords
- melting point
- glycine
- acetyl
- ester
- formula
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract description 4
- -1 alkyl radical Chemical class 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000006072 paste Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 3
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000969 carrier Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 description 66
- 230000008018 melting Effects 0.000 description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- LYADVSFOGGOFSF-UHFFFAOYSA-N hexadecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CNC(C)=O LYADVSFOGGOFSF-UHFFFAOYSA-N 0.000 description 13
- 239000008389 polyethoxylated castor oil Substances 0.000 description 12
- YXPUCEVREIKCKU-UHFFFAOYSA-N hexadecyl 2-benzamidoacetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CNC(=O)C1=CC=CC=C1 YXPUCEVREIKCKU-UHFFFAOYSA-N 0.000 description 10
- 239000013543 active substance Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 239000002304 perfume Substances 0.000 description 7
- UEYROBDNFIWNST-UHFFFAOYSA-N N-octadecanoylglycine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCC(O)=O UEYROBDNFIWNST-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 6
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 4
- XPRHECSNKPCUGF-UHFFFAOYSA-N 4-[(4-phenylbenzoyl)amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1C1=CC=CC=C1 XPRHECSNKPCUGF-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- QDKAKIGZFIBLBC-IBGZPJMESA-N hexadecyl (2s)-2-acetamidopropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)[C@H](C)NC(C)=O QDKAKIGZFIBLBC-IBGZPJMESA-N 0.000 description 3
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 description 2
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 2
- CWXYHOHYCJXYFQ-UHFFFAOYSA-N Betamipron Chemical compound OC(=O)CCNC(=O)C1=CC=CC=C1 CWXYHOHYCJXYFQ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- DYUGTPXLDJQBRB-UHFFFAOYSA-N N-myristoylglycine Chemical compound CCCCCCCCCCCCCC(=O)NCC(O)=O DYUGTPXLDJQBRB-UHFFFAOYSA-N 0.000 description 2
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- VSNYYQYIMXOCBC-UHFFFAOYSA-N hexadecyl 2-[acetyl(methyl)amino]acetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CN(C)C(C)=O VSNYYQYIMXOCBC-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- BMRJSITXXVEEHU-UHFFFAOYSA-N octadecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CNC(C)=O BMRJSITXXVEEHU-UHFFFAOYSA-N 0.000 description 2
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
- UBENNUYJTVOWIV-SANMLTNESA-N (2s)-2-(docosanoylamino)-4-methylpentanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(C)C UBENNUYJTVOWIV-SANMLTNESA-N 0.000 description 1
- RKQUHHNIJVGMIG-IBGZPJMESA-N (2s)-2-(dodecanoylamino)-3-phenylpropanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 RKQUHHNIJVGMIG-IBGZPJMESA-N 0.000 description 1
- CDOCNWRWMUMCLP-INIZCTEOSA-N (2s)-2-(dodecanoylamino)-4-methylpentanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(C)C CDOCNWRWMUMCLP-INIZCTEOSA-N 0.000 description 1
- BPAJFJUFJGPGJS-NSHDSACASA-N (2s)-2-[(4-phenylbenzoyl)amino]propanoic acid Chemical compound C1=CC(C(=O)N[C@@H](C)C(O)=O)=CC=C1C1=CC=CC=C1 BPAJFJUFJGPGJS-NSHDSACASA-N 0.000 description 1
- FTIQEVPFMLQJJT-QFIPXVFZSA-N (2s)-4-methyl-2-(octadecanoylamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(C)C FTIQEVPFMLQJJT-QFIPXVFZSA-N 0.000 description 1
- GAYBJDZLMVRVKL-SFHVURJKSA-N (2s)-4-methyl-2-(tetradecanoylamino)pentanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(C)C GAYBJDZLMVRVKL-SFHVURJKSA-N 0.000 description 1
- WQHXCNGQDLRDMP-UHFFFAOYSA-N 2-(dodecanoylamino)-3-methylbutanoic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(C)C)C(O)=O WQHXCNGQDLRDMP-UHFFFAOYSA-N 0.000 description 1
- UYTOHYBIBPDOKX-UHFFFAOYSA-N 2-(dodecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCC(=O)NC(C)C(O)=O UYTOHYBIBPDOKX-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- RJYOKYDKKOFLBT-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O RJYOKYDKKOFLBT-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- XGYJHOKDLDLGLP-UHFFFAOYSA-N 3-methyl-2-(tetradecanoylamino)butanoic acid Chemical compound CCCCCCCCCCCCCC(=O)NC(C(C)C)C(O)=O XGYJHOKDLDLGLP-UHFFFAOYSA-N 0.000 description 1
- BIXOTZHITGYMGF-UHFFFAOYSA-N 4-(dodecanoylamino)butanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC(O)=O BIXOTZHITGYMGF-UHFFFAOYSA-N 0.000 description 1
- BOZHPKGNNJPZKV-UHFFFAOYSA-N 4-benzamidobutanoic acid Chemical compound OC(=O)CCCNC(=O)C1=CC=CC=C1 BOZHPKGNNJPZKV-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- UEWVQOCQZFYTBW-FQEVSTJZSA-N N-Palmitoyl leucine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(C)C UEWVQOCQZFYTBW-FQEVSTJZSA-N 0.000 description 1
- BAHIJPSQSKWCJX-QHCPKHFHSA-N N-Palmitoyl phenylalanine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 BAHIJPSQSKWCJX-QHCPKHFHSA-N 0.000 description 1
- CCGXSETVBNBVKJ-UHFFFAOYSA-N N-Stearoyl GABA Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCC(O)=O CCGXSETVBNBVKJ-UHFFFAOYSA-N 0.000 description 1
- UYZIMGIUGBXMOC-IBGZPJMESA-N N-Stearoyl alanine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(O)=O UYZIMGIUGBXMOC-IBGZPJMESA-N 0.000 description 1
- SIPMISGYHBUSIB-QFIPXVFZSA-N N-Stearoyl valine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C(C)C)C(O)=O SIPMISGYHBUSIB-QFIPXVFZSA-N 0.000 description 1
- WRRYZYASRAUROW-UHFFFAOYSA-N N-decanoylglycine Chemical compound CCCCCCCCCC(=O)NCC(O)=O WRRYZYASRAUROW-UHFFFAOYSA-N 0.000 description 1
- YQPHTLSGFSVOOM-UHFFFAOYSA-N N-docosanoylglycine Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCC(O)=O YQPHTLSGFSVOOM-UHFFFAOYSA-N 0.000 description 1
- JWGGSJFIGIGFSQ-UHFFFAOYSA-N N-dodecanoylglycine Chemical compound CCCCCCCCCCCC(=O)NCC(O)=O JWGGSJFIGIGFSQ-UHFFFAOYSA-N 0.000 description 1
- KVTFEOAKFFQCCX-UHFFFAOYSA-N N-hexadecanoylglycine Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(O)=O KVTFEOAKFFQCCX-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000669 acetylleucine Drugs 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- WRVCBEDPEXSXRS-UHFFFAOYSA-N docosyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)CNC(C)=O WRVCBEDPEXSXRS-UHFFFAOYSA-N 0.000 description 1
- CUFAAXYRGGHNRD-UHFFFAOYSA-N docosyl 2-benzamidoacetate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)CNC(=O)C1=CC=CC=C1 CUFAAXYRGGHNRD-UHFFFAOYSA-N 0.000 description 1
- AGQOWIQTOLXPSG-UHFFFAOYSA-N dodecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCOC(=O)CNC(C)=O AGQOWIQTOLXPSG-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- KSURPZTYEZTWKV-UHFFFAOYSA-N ethyl 2-(octadecanoylamino)acetate Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCC(=O)OCC KSURPZTYEZTWKV-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- YSXNWFFVMGPXCJ-UHFFFAOYSA-N heptadecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCCOC(=O)CNC(C)=O YSXNWFFVMGPXCJ-UHFFFAOYSA-N 0.000 description 1
- NIIPYHOZKXVLRP-SANMLTNESA-N hexadecyl (2s)-2-acetamido-3-phenylpropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)[C@@H](NC(C)=O)CC1=CC=CC=C1 NIIPYHOZKXVLRP-SANMLTNESA-N 0.000 description 1
- CYTDXJPQKHFCCP-QFIPXVFZSA-N hexadecyl (2s)-2-acetamido-4-methylsulfanylbutanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)[C@@H](NC(C)=O)CCSC CYTDXJPQKHFCCP-QFIPXVFZSA-N 0.000 description 1
- HDXUNYNNJBUJCZ-UHFFFAOYSA-N hexadecyl 2-(propanoylamino)acetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CNC(=O)CC HDXUNYNNJBUJCZ-UHFFFAOYSA-N 0.000 description 1
- AHQHOPAYZDUMJQ-UHFFFAOYSA-N hexadecyl 2-[(2,2,2-trifluoroacetyl)amino]acetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CNC(=O)C(F)(F)F AHQHOPAYZDUMJQ-UHFFFAOYSA-N 0.000 description 1
- UEVBYTOVPKCIFD-UHFFFAOYSA-N hexadecyl 2-[(4-nitrobenzoyl)amino]acetate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CNC(=O)C1=CC=C([N+]([O-])=O)C=C1 UEVBYTOVPKCIFD-UHFFFAOYSA-N 0.000 description 1
- FVIOAENSSAKWNB-UHFFFAOYSA-N hexadecyl 2-[(4-phenylbenzoyl)amino]acetate Chemical compound C1=CC(C(=O)NCC(=O)OCCCCCCCCCCCCCCCC)=CC=C1C1=CC=CC=C1 FVIOAENSSAKWNB-UHFFFAOYSA-N 0.000 description 1
- CGNFRHKLZQDCEP-UHFFFAOYSA-N icosyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCCCCCOC(=O)CNC(C)=O CGNFRHKLZQDCEP-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- RNRAOYMRAIMUJA-FQEVSTJZSA-N methyl (2s)-2-(octadecanoylamino)propanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)OC RNRAOYMRAIMUJA-FQEVSTJZSA-N 0.000 description 1
- XHSSIAMKKYLJRP-UHFFFAOYSA-N methyl 2-(octadecanoylamino)acetate Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCC(=O)OC XHSSIAMKKYLJRP-UHFFFAOYSA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- JIXXHVHZXWYDIE-UHFFFAOYSA-N nonadecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCCCCCOC(=O)CNC(C)=O JIXXHVHZXWYDIE-UHFFFAOYSA-N 0.000 description 1
- WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 1
- CDFLQWGDSCYYAU-NRFANRHFSA-N octadecyl (2s)-2-acetamidopropanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)[C@H](C)NC(C)=O CDFLQWGDSCYYAU-NRFANRHFSA-N 0.000 description 1
- LKHUFWJSLTVYOR-UHFFFAOYSA-N octadecyl 2-aminoacetate;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCCCOC(=O)CN LKHUFWJSLTVYOR-UHFFFAOYSA-N 0.000 description 1
- AYMPFLYXLAXARD-UHFFFAOYSA-N octadecyl 4-acetamidobutanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCNC(C)=O AYMPFLYXLAXARD-UHFFFAOYSA-N 0.000 description 1
- VTFSEVMPXKHECO-UHFFFAOYSA-N octadecyl 4-benzamidobutanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCNC(=O)C1=CC=CC=C1 VTFSEVMPXKHECO-UHFFFAOYSA-N 0.000 description 1
- RQWJKBWXVWNOHJ-UHFFFAOYSA-N pentadecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCCOC(=O)CNC(C)=O RQWJKBWXVWNOHJ-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- MMCDZAKGZURAAD-NDEPHWFRSA-N propan-2-yl (2s)-2-(octadecanoylamino)-3-phenylpropanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)OC(C)C)CC1=CC=CC=C1 MMCDZAKGZURAAD-NDEPHWFRSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- WLSVOGRCAVYIOG-UHFFFAOYSA-N tetradecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCCOC(=O)CNC(C)=O WLSVOGRCAVYIOG-UHFFFAOYSA-N 0.000 description 1
- WKLABMSRTPMGEI-UHFFFAOYSA-N tetradecyl 4-acetamidobutanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCNC(C)=O WKLABMSRTPMGEI-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- PWYKVOJAVZHYAJ-UHFFFAOYSA-N tridecyl 2-acetamidoacetate Chemical compound CCCCCCCCCCCCCOC(=O)CNC(C)=O PWYKVOJAVZHYAJ-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Acylaminocarboxylic acid compsns for treatment and protection of skin
Description
In der Literatur werden zahlreiche Acyl-amino-carbonsäure-derivate (siehe beispielsweise C. A. 66, 29058 (1967)) beschrieben; in diesen Literaturstellen werden keinerlei biologische Wirkungsangaben gemacht.
Es wurde nun überraschenderweise festgestellt, dass die Verbindungen der Formel I
EMI1.1
worin Rt ein Wasserstoffatom, einen geradkettigen oder verzweigten Alkylrest mit 1 bis 24 Kohlenstoffatomen, eine Trifluorme- ethylgruppe einen gegebenenfalls durch eine Alkylgruppe, ein Halogenatom oder Nitrogruppe substituierten Phenylrest oder einen Biphenylrest; R2 ein Wasserstoffatom oder einen Alkylrest mit 1 bis 3 Kohlenstoffatomen; R3 ein Wasserstoffatom, einen gegebenenfalls durch eine Methylthiogruppe substituierten Alkylrest mit 1 bis 6 Kohlenstoffatomen oder einen Benzylrest; R4 ein Wasserstoffatom oder einen geradkettigen oder verzweigten Alkylrest mit 1 bis 24 Kohlenstoffatomen;
und n Null, 1 oder 2 bedeuten, wervolle kosmetische Eigenschaften besitzen, insbesondere zur Pflege der Haut.
Die Verbindungen der Formel I lassen sich, gegebenenfalls in Kombination mit Keratolytika, Desinfizienzien und dergleichen, in die üblichen zur Anwendung auf der Haut geeigneten Zubereitungsformen wie Salben, Cremes, Aerosole, Puder, Tinkturen, Gele, Pasten, Essenzen oder Lotions, z. B. in einer Konzentration von 0,1 bis 20%, vorzugsweise 0,25 bis 5 %, einarbeiten. Gegenstand der vorliegenden Erfindung sind somit neue Hautpflegemittel.
Die Verbindung der Formel I, welche zum grössten Teil literaturbekannt sind, lassen sich beispielsweise durch Acylierung einer Verbindung der Formel II
EMI1.2
mit einem reaktionsfähigen Derivat einer Säure der Formel III Rl COOH (III) herstellen.
Die Acylierung erfolgt vorzugsweise mit einem reaktionsfähigen Derivat einer Säure der Formel III, z. B. ihrem Anhydrid oder Halogenid, zweckmässigerweise in einem Lösungsmittel wie Wasser in Gegenwart einer Base wie Natriumhydroxyd oder Pyridin bei Temperaturen zwischen 0 und 100"C.
Wie bereits eingangs-erwähnt, weisen die Verbindungen der Formel I wertvolle kosmetische Eigenschaften für die Pflege der Haut auf. Sie besitzen insbesondere eine talgdrüsenhemmeride, hautpflegende und hautfeuchtigkeitssteigernde Wirkung, wobei sich die Verbindungen der Formel I, in denen Rt einen niederen Alkylrest, eine Phenyl- oder Biphenylylgruppe, R2 und R3 Wasserstoffatome, R4 ein Wasserstoffatom oder einen Alkylrest mit 14 bis 18 Kohlenstoffatomen und n die Zahl Null, 1 oder 2 bedeuten, als besonders wirksam erwiesen haben.
Die wertvollen kosmetischen Eigenschaften der Verbindungen der Formel I können beispielsweise nach folgender Methode nachgewiesen werden:
Bestimmung der Beeinflussung der Hautfettung nach der Glasklötzchen-Methode (siehe Schaefer und Kuhn-Bussius, Arch. Klin. exper. Derm., 238,429-435 (1970)):
Aufgerauhte Glasklötzchen werden auf die zu messenden
Hautpartien aufgedrückt. Das vorhandene Hautfett macht die
Glasklötzchen durchsichtiger. Anschliessend wird die Trans mission im Photometer gemessen. Vor der Messung der Rück fettung der Haut wird das vorhandene Hautfett mit Plastikfolie abgenommen.
Die zu untersuchenden Substanzen wurden halbseitig auf der Stirn bei 5 bis 10 Versuchspersonen mit 0,25 ml einer
5 %igen alkoholischen Lösung der jeweiligen Substanz gegen über Kontrollen (0,25 ml Alkohol) aufgetragen. Nach 1 '/2
Stunden erfolgt die Folienentfettung und nach weiteren 3
Stunden wurde die Rückfettung bestimmt.
Die prozentuale
Steigerung der Durchsichtigkeit der abgedrückten Klötzchen ist proportional der vorhandenen Hautfettmenge:
Substanz mittlere Extinktionswerte
Kontrolle Behandlung Differenz
N-Acetyl-glycin hexadecylester 66,0 75,5 9,5
N-Acetyl-alanin hexadecylester 66,5 74,0 7,5
N-Benzoyl-glycin hexadecylester 62,0 78,5 16,5
N-Acetyl-sarcosin hexadecylester 77,5 86,5 9,0
N-Octanoyl-glycin 60,0 78,0 18,0
Die nachfolgenden Beispiele sollen die Erfindung näher erläutern:
Beispiel A
N-Acetyl-glycin-octadecylester
3,0 g Glycinäthylester-hydrochlorid und 15,0 g Octadecanol werden auf 100oC erhitzt und bei dieser Temperatur 3 Stunden lang Salzsäuregas eingeleitet. Nach dem Abkühlen wird die erstarrte Schmelze in 500 ml Äther aufgeschlämmt und der feste Rückstand des Glycinoctadecylester-hydrochlorids abgesaugt.
Das rohe Ester-hydrochlorid wird in Wasser aufgeschlämmt und die Base unter Rühren durch Zugabe von Natriumbikarbonat im Überschuss freigesetzt, abgesaugt und getrock net. Der Ester wird in 50 ml Acetanhydrid gegeben und eine
Stunde auf dem Wasserbad erhitzt. Anschliessend wird die Lösung in 1 l Wasser gegeben und die entstandene Fällung des acetylierten Esters abgesaugt und getrocknet. Zur Reinigung wird das Rohprodukt 3 mal aus Petroläther umkristallisiert.
Ausbeute: 2,1 g (26% der Theorie), Schmelzpunkt: 78-790C.
Beispiel B
N-Octadecanoyl-glycin
7,5 g (0,1 Mol) Glycin werden in einer Lösung von 4,0 g (0,1 Mol) Natriumhydroxid in 150 ml Wasser gelöst. Dazu gibt man 30 g (0,1 Mol) Octadecanoylchlorid und schüttelt kräftig, bis das Produkt fest wird. Man säuert mit konzentrierter Salz säure an, saugt ab und wäscht mit Wasser nach. Nach dem Trocknen des Festproduktes wird es 2 mal aus Essigester umkristallisiert.
Ausbeute: 25 g (73 % der Theorie), Schmelzpunkt: 120OC.
Analog den Beispielen A und B wurden folgende Verbin dungen hergestellt (siehe beispielsweise Rec. trav. chim. 77,
267 (1958) oder J. Am. Chem. Soc. 78, 172 (956)):
N-Acetyl -leucin-hexadecylester
Schmelzpunkt: 37-38 C N-Acetyl-methionin-hexadecylester
Schmelzpunkt: 59-60 C N-Acetyl-phenylalanin-hexadecylester Schmelzpunkt: 75-760C N-Acetyl -sarcosin-hexadecylester Schmelzpunkt: 58-59 C N -Formyl-glycin-hexadecylester Schmelzpunkt: 64-65 C N-Propionyl-glycin-hexadecylester Schmelzpunkt: 67-680C N-Trifluoracetyl-glycin-hexadecylester Schmelzpunkt: 68-70 C N-Benzoyl-glycin-hexadecylester Schmelzpunkt: 59-60 C N-4-Phenylbenzoyl-glycin-hexadecylester Schmelzpunkt:
103 C N-4-Chlorbenzoyl-glyein-hexadecylester Schmelzpunkt: 85-860C N-4-Nitrobenzoyl-glycin-hexadecylester Schmelzpunkt: 102-1030C N -Acetyl- -alanin-hexadecylester Schmelzpunkt: 65-660C N-Benzoyl -glycin-docosylester Schmelzpunkt: 78-79 C N-Acetyl-glycin-dodecylester Schmelzpunkt: 59-600C N-Acetyl -glycin-tridecylester Schmelzpunkt: 65-660C N-Acetyl-glycin-tetradecylester Schmelzpunkt: 69-700C N-Acetyl-glyein-pentadecylester Schmelzpunkt: 73-74 C N- Acetyl-glycin-hexadecylester Schmelzpunkt: 74-75oC N-Acetyl-glycin-heptadecylester Schmelzpunkt:
76-77 C N-Acetyl -glycin-octadecylester Schmelzpunkt: 78-790C N-Acetyl-glycin-nonadecylester Schmelzpunkt: 79-800C N- Acetyl-glycin-eicosylester Schmelzpunkt: 83-84 C N-Acetyl -glycin-docosylester Schmelzpunkt: 86-870C N-Acetyl-alanin-hexadecylester Schmelzpunkt: 64-65 C N-Acetyl-alanin-octadecylester Schmelzpunkt: 70-7 10C N-Acetyl-ss-alanin-eicosylester Schmelzpunkt: 76 C N-Acetyl-ss-alanin-dodecylester Schmelzpunkt: 50 C N-Benzoyl-ss-alanin-dodecylester Schmelzpunkt: 56 C N-Acetyl-4-aminobuttersäure-tetradecylester Schmelzpunkt: 580C N-Acetyl-4-aminobuttersäure-octadecylester Schmelzpunkt: 71 C N-Benzoyl-4-aminobuttersäure-octadecylester Schmelzpunkt: 76 C N-Dodecanoyl-glycin Schmelzpunkt:
120 C
N-Tetradecanoyl-glycin Schmelzpunkt: 1250C N-Hexadecanoyl-glycin Schmelzpunkt: 123-1260C N-Octadecanoyl-glycin Schnelzpunkt: 1200C N-Docosanoyl-glycin Schmelzpunkt: 1210C N-Octadecanoyl-alanin Schmelzpunkt: 109 C N-Dodecanoyl-valin Schmelzpunkt: 107 C N-Tetradecanoyl-valin Schmelzpunkt: 980C N-Octadecanoyl-valin Schmelzpunkt: 930C N-Dodecanoyl-leucin Schmelzpunkt: 109oC N-Tetradecanoyl-leucin Schmelzpunkt: 102 C N-Hexadecanoyl-leucin Schmelzpunkt: 88-890C N-Octadecanoyl-leucin Schmelzpunkt: 960C N-Docosanoyl-leucin Schmelzpunkt: 980C N -Hexadecanoyl-sarcosin Schmelzpunkt: 65-660C N-Octanoyl-glycin Schmelzpunkt: 109 C N-Decanoyl-glycin Schmelzpunkt:
114 C N-Hexadecanoyl -ss-alanin Schmelzpunkt: 117-1180C N-Benzoyl-ss-alanin Schmelzpunkt: 103-105oC N -4-Phenylbenzoyl- -alanin Schmelzpunkt: 103-105"C N-Dodecanoyl-4-amino-buttersäure Schmelzpunkt: 92-93 C N-Octadecanoyl-4-amino-buttersäure Schmelzpunkt: 100-1020C N-Benzoyl-4-amino-buttersäure Schmelzpunkt: 88-890C N-4 -Phenylbenzoyl-4-amino-buttersäure Schmelzpunkt: 181 C N-Tetradecanoyl-sarcosin Schmelzpunkt: 51-520C N-Octadecanoyl-sarcosin Schmelzpunkt: 71-720C N-Dodecanoyl-alanin Schmelzpunkt: 104-105oC N-Dodecanoyl-phenylalanin Schmelzpunkt:
100oC N-Hexadecanoyl-phenylalanin Schmelzpunkt: 98-99 C N-Octadecanoyl -glycin-methylester Schmelzpunkt: 83-84 C N-Octadecanoyl-glycin-äthylester Schmelzpunkt: 82-83 C N-Octadecanoyl-alanin-methylester Schmelzpunkt: 76-770C N-Octadecanoyl -phenylalanin-isopropylester Schmelzpunkt: 69-70 C
Beispiel 1
Creme mit N-Acetyl-glycin-hexadecylester Zusammensetzung: N-Acetyl-glycin-hexadecylester 3,0 g Benzalkon A 0,1 g Cremophor 0 4,0 g Glyzerinmonostearat 4,0 g Lanette 0 5,0 g Walrat 3,0 g Cetiol V 10,0g dest. Wasser ad 100,0 g
Herstellung
Benzalkon wird in 700C warmem Wasser gelöst (I). In die Schmelze (70 C) von Cremophor 0, Glyzerinmonostearat, Lanette 0, Walrat Cetiol V wird die Wirksubstanz einsuspendiert (II). II wird in I bei 70 C einemulgiert, anschliessend wird kaltgerührt.
Beispiel 2
Creme mit N-Octadecanoyl-glycin Zusammensetzung: N-Octadecanoyl-glycin 1,0 g Benzalkon A 0,1 g Cremophor 0 4,0 g Glyzerinmonostearat 4,0 g Lanette 0 5,0 g Walrat 3,0 g Cetiol V 10,0 g dest. Wasser ad 100,0 g Herstellung: analog Beispiel 1.
Beispiel 3
Salbe mit N-Benzoyl-glycin-hexadecylester Zusammensetzung: N-Benzoyl-glycin-hexadecylester 3,0 g Cremophor 0 6,0 g Cremophor A fest 1,0 g Wollfett 2,0 g Paraffinöl 45,0g Vaseline ad 100,0 g
Herstellung
Cremophor 0, Cremophor A fest, Wollfett, Paraffinöl und Vaseline wird bei 700C zusammengeschmolzen und die Wirksubstanz einsuspendiert, anschliessend wird kaltgerührt.
Beispiel 4
Gel mit N-Acetyl-glycin-hexadecylester Zusammensetzung: N-Acetyl-glycin-hexadecylester 3,0 g Carbopol 940 0,6 g Triäthanolamin 0,6 g Cremophor EL 5,0 g Isopropanol 30,0 g dest. Wasser ad 100,0 g
Herstellung
Die Lösung der Wirksubstanz, Cremophor EL und Triäthanolamin in Isopropanol wird in die wässrige Lösung von Car bopol eingerührt.
Beispiel 5
Badeessenz mit N-Acetyl-glycin-hexadecylester
Zusammensetzung: N-Acetyl-glycin-hexadecylester 5,0 g Texapon N 25 30,0 g Comperlan OD 5,0 g Isopropanol 20,0 g äther. Öl 2,0 g dest. Wasser ad 100,0 g
Herstellung
Die Lösung der Wirksubstanz und des ätherischen Öls in Isopropanol wird in die wässrige Lösung von Texapon N 25 und Comperlan OD eingerührt.
Beispiel 6
Haartinktur mit N-Tetradecanol-glycin
Zusammensetzung:
N-Tetradecanoyl-glycin 0,25 g Isoadipat 0,2 g
Parfümöl 0,1 g
Isopropanol 50,0 g dest. Wasser ad 100,0 g
Herstellung
Die Wirksubstanz, Isoadipat und Parfümöl wird in Isopropanol gelöst und anschliessend unter Rühren Wasser zugegeben.
Beispiel 7
Trockenspray mit N-Acetyl-glycin-hexadecylester Zusammensetzung: N-Acetyl-glycin-hexadecylester 3,0 g Span 85 0,4 g Frigen 11 A 3,0 g Frigen 12/114 40:60 93,6 g
Herstellung
Die Wirksubstanz, Span 85 und Frigen 11 werden in einer
Kugelmühle vermischt. Diese auf - 150C abgekühlte Mischung wird in die auf -40 bis - 50 C abgekühlte Treibgasmischung langsam eingetragen und unter Rühren abgefüllt.
Beispiel 8
Schaum-Aerosol mit N-Benzoyl-glycin-hexadecylester Zusammensetzung: N-Benzoyl-glycin-hexadecylester 3,0 g
Cremophor EL 1,0 g Tween 80 1,2 g Texapon N 25 0,8 g Äthanol 94%ig 21,0 g Wasser dest. 57,0 g Frigen 12/114 60:40 16,0 g
Herstellung
Die Wirksubstanz wird in Äthanol gelöst (I). Cremophor
EL, Tween 80 und Texapon N 25 wird in Wasser gelöst (II). I wird unter Rühren in II eingetragen und das erhaltene Konzentrat in Dosen abgefüllt. Nach dem Verschliessen mit einem
Ventil wird das Treibgas eingepresst.
Beispiel 9
Creme mit N-Benzoyl-glycin-hexadecylester Zusammensetzung: N-Benzoyl-glycin-hexadecylester 3,0 g Benzalkon A 0,1 g Cremophor 0 4,0 g Glyzerinmonostearat 4,0 g Lanette 0 5,0 g Walrat 3,0 g Cetiol V 10,0 g Vitamin-A-Acetat 30 000 I.E.
Vitamin-E-Acetat 20 je.
dest. Wasser ad 100,0 g Herstellung: analog Beispiel 1
Beispiel 10
Lotio mit N-Octadecanoyl-glycin Zusammensetzung: N-Octadecanoyl-glycin 3,0 g Span 40 3,0 g Cremophor 0 2,0 g Lanette 0 2,0 g Walrat 1,0 g Cetiol V 5,0 g Paraffinöl subl. 1,0 g Nipagin M 0,1 g dest. Wasser ad 100,0 g
Herstellung
Span 40, Cremophor 0, Lanette 0, Walrat, Cetiol V und Paraffinöl wird bei 700C geschmolzen und darin die Wirksubstanz gelöst. Dest. Wasser wird auf 800C erhitzt und darin Nipagin gelöst, nach dem Abkühlen auf 700C wird die Fettschmelze eingetragen, homogenisiert und kaltgerührt.
Beispiel 11
Shampoo mit N-Acetyl-glycin-hexadecylester Zusammensetzung: N-Acetyl-glycin-hexadecylester 3,0 g Zetesol SE 35 T 55,0 g Tylose MH 300 1,0 g Nipagin M 0,5 g dest. Wasser ad 100,0 g
Herstellung
Dest. Wasser wird auf 800C erhitzt, darin Nipagin M gelöst und Tylose suspendiert. In Zetesol und Parfümöl wird die Wirksubstanz mittels Schnellrührer verteilt, dem Tyloseschleim zugegeben, homogenisiert und entlüftet.
Beispiel 12
Puder mit N-Acetyl-glycin-hexadecylester Zusammensetzung: N-Acetyl-glycin-hexadecylester 3,0 g Aerosil 1,0 g Magnesiumstearat 0,2 g ANM Maisstärke ad 100,0 g
Herstellung
In 1/3 der Maisstärke werden nacheinander Wirksubstanzen, Aerosil und Magnesiumstearat gegeben und gut durchmischt. Anschliessend wird die restliche Menge Maisstärke hinzugegeben und nochmals gut durchmischt.
Beispiel 13
Paste mit N-(4'-Phenylbenzoyl)-4-aminobuttersäure Zusammensetzung: N-(4'-Phenylbenzoyl)-4-aminobuttersäure 3,0 g Lanogen 1500 20,0 g Isopropanol 45,0 g Veegum pharm. 10,0 g Pigment und Farbstoff 1,0 g Parfümöl 0,2 g dest. Wasser ad 100,0 g
Herstellung Die Wirksubstanz wird in Lanogen bei 600C gelöst (I). Parfümöl wird in Isopropanol gelöst (II). Dest. Wasser wird auf 600C erwärmt, darin Veegum verteilt und quellen gelassen.
Hierzu gibt man II und I, es wird durchgeknetet und homogenisiert.
Beispiel 14
Tinktur mit N-B enzoyl-glycin-hexadecylester Zusammensetzung: N-Benzoyl-glycin-hexadecylester 3,0 g Isopropanol 25, Og Äthanol 95 %ig rein 25,0 g Parfümöl 0,2 g dest. Wasser ad 100,0 g
Herstellung
Isopropanol und Äthanol werden auf 600C erwärmt und darin Parfütnöl und die Wirksubstanz gelöst. Anschliessend gibt man Wasser zu, kühlt ab und filtriert.
Auf die gleiche Weise können alle Verbindungen der For mel I in die üblichen Zubereitungsformen eingearbeitet werden.
Der Schutzumfang des Patentes ist beschränkt durch Art. 1, Ziff. 2. PatG.
Numerous acylamino-carboxylic acid derivatives are described in the literature (see, for example, C. A. 66, 29058 (1967)); no biological activity information is given in these literature references.
It has now surprisingly been found that the compounds of the formula I
EMI1.1
wherein Rt is a hydrogen atom, a straight-chain or branched alkyl radical having 1 to 24 carbon atoms, a trifluoromethyl group, a phenyl radical which is optionally substituted by an alkyl group, a halogen atom or a nitro group, or a biphenyl radical; R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms; R3 represents a hydrogen atom, an alkyl radical having 1 to 6 carbon atoms which is optionally substituted by a methylthio group or a benzyl radical; R4 is a hydrogen atom or a straight-chain or branched alkyl radical having 1 to 24 carbon atoms;
and n means zero, 1 or 2, have valuable cosmetic properties, especially for skin care.
The compounds of the formula I can, if appropriate in combination with keratolytics, disinfectants and the like, in the usual preparation forms suitable for use on the skin, such as ointments, creams, aerosols, powders, tinctures, gels, pastes, essences or lotions, e.g. B. in a concentration of 0.1 to 20%, preferably 0.25 to 5%, incorporate. The present invention thus relates to new skin care products.
The compounds of the formula I, most of which are known from the literature, can be obtained, for example, by acylating a compound of the formula II
EMI1.2
with a reactive derivative of an acid of the formula III Rl COOH (III).
The acylation is preferably carried out with a reactive derivative of an acid of the formula III, e.g. B. its anhydride or halide, conveniently in a solvent such as water in the presence of a base such as sodium hydroxide or pyridine at temperatures between 0 and 100 "C.
As already mentioned at the beginning, the compounds of the formula I have valuable cosmetic properties for the care of the skin. In particular, they have a sebum-inhibiting, skin-care and skin-moisturizing effect, the compounds of the formula I in which Rt is a lower alkyl radical, a phenyl or biphenylyl group, R2 and R3 are hydrogen atoms, R4 is a hydrogen atom or an alkyl radical having 14 to 18 carbon atoms and n the number zero, 1 or 2 have proven to be particularly effective.
The valuable cosmetic properties of the compounds of the formula I can be demonstrated, for example, using the following method:
Determination of the influence on skin lipid using the glass block method (see Schaefer and Kuhn-Bussius, Arch. Klin. Exper. Derm., 238, 429-435 (1970)):
Roughened glass blocks are on the to be measured
Areas of skin pressed. The existing skin oil does that
Glass blocks more transparent. The transmission is then measured in the photometer. Before the measurement of the lipid regrowth of the skin, the existing skin oil is removed with plastic film.
The substances to be examined were placed on one side of the forehead of 5 to 10 test persons with 0.25 ml of a
5% alcoholic solution of the respective substance is applied against controls (0.25 ml alcohol). After 1 '/ 2
The film is degreased after a further 3 hours
The refatting was determined for hours.
The percentage
The increase in transparency of the pressed blocks is proportional to the amount of skin fat present:
Substance mean absorbance values
Control treatment difference
N-acetyl-glycine hexadecyl ester 66.0 75.5 9.5
N-acetyl-alanine hexadecyl ester 66.5 74.0 7.5
N-benzoyl-glycine hexadecyl ester 62.0 78.5 16.5
N-acetyl-sarcosine hexadecyl ester 77.5 86.5 9.0
N-octanoyl glycine 60.0 78.0 18.0
The following examples are intended to explain the invention in more detail:
Example A
N-acetyl-glycine-octadecyl ester
3.0 g of glycine ethyl ester hydrochloride and 15.0 g of octadecanol are heated to 100 ° C. and hydrochloric acid gas is passed in at this temperature for 3 hours. After cooling, the solidified melt is suspended in 500 ml of ether and the solid residue of the glycine octadecyl ester hydrochloride is suctioned off.
The crude ester hydrochloride is suspended in water and the base is released with stirring by adding excess sodium bicarbonate, filtered off with suction and dried. The ester is added to 50 ml of acetic anhydride and a
Heated on the water bath for an hour. The solution is then poured into 1 l of water and the resulting precipitate of the acetylated ester is filtered off with suction and dried. For purification, the crude product is recrystallized 3 times from petroleum ether.
Yield: 2.1 g (26% of theory), melting point: 78-790C.
Example B.
N-octadecanoyl glycine
7.5 g (0.1 mol) of glycine are dissolved in a solution of 4.0 g (0.1 mol) of sodium hydroxide in 150 ml of water. Add 30 g (0.1 mol) of octadecanoyl chloride and shake vigorously until the product solidifies. It is acidified with concentrated hydrochloric acid, filtered off with suction and washed with water. After the solid product has dried, it is recrystallized twice from ethyl acetate.
Yield: 25 g (73% of theory), melting point: 120 ° C.
The following compounds were prepared analogously to Examples A and B (see, for example, Rec. Trav. Chim. 77,
267 (1958) or J. Am. Chem. Soc. 78, 172 (956)):
N-acetylleucine hexadecyl ester
Melting point: 37-38 C, N-acetyl methionine hexadecyl ester
Melting point: 59-60 C N-acetyl-phenylalanine-hexadecyl ester Melting point: 75-760C N-acetyl-sarcosine-hexadecyl ester Melting point: 58-59 CN -formyl-glycine-hexadecyl ester Melting point: 64-65 C N-propionyl-glycine-hexadecyl ester Melting point: 67-680C N-Trifluoroacetyl-glycine-hexadecyl ester Melting point: 68-70 C N-Benzoyl-glycine-hexadecyl ester Melting point: 59-60 C N-4-phenylbenzoyl-glycine-hexadecyl ester melting point:
103 C N-4-chlorobenzoyl-glyein-hexadecyl ester melting point: 85-860C N-4-nitrobenzoyl-glycine-hexadecyl ester melting point: 102-1030C N -acetyl-alanine-hexadecyl ester melting point: 65-660C N-benzoyl-glycine-docosyl ester Melting point: 78-79 C, N-acetyl-glycine dodecyl ester, melting point: 59-600C, N-acetyl-glycine tridecyl ester, melting point: 65-660C, N-acetyl-glycine tetradecyl ester, melting point: 69-700C, N-acetyl-glycine pentadecyl ester, melting point : 73-74 C N-acetyl-glycine-hexadecyl ester melting point: 74-75oC N-acetyl-glycine-heptadecyl ester melting point:
76-77 C N-acetyl-glycine-octadecyl ester melting point: 78-790C N-acetyl-glycine-nonadecyl ester melting point: 79-800C N-acetyl-glycine-eicosyl ester melting point: 83-84 C N-acetyl-glycine-docosyl ester melting point: 86-870C N-acetyl-alanine-hexadecyl ester melting point: 64-65 C N-acetyl-alanine-octadecyl ester melting point: 70-7 10C N-acetyl-ss-alanine-eicosyl ester melting point: 76 C N-acetyl-ss-alanine- dodecyl ester melting point: 50 C N-benzoyl-ss-alanine dodecyl ester melting point: 56 C N-acetyl-4-aminobutyric acid tetradecyl ester melting point: 580C N-acetyl-4-aminobutyric acid octadecyl ester melting point: 71 C N-benzoyl-4-aminobutyric acid octadecyl ester melting point: 76 C N-dodecanoyl glycine melting point:
120 C
N-tetradecanoyl-glycine melting point: 1250C N-hexadecanoyl-glycine melting point: 123-1260C N-octadecanoyl-glycine melting point: 1200C N-docosanoyl-glycine melting point: 1210C N-octadecanoyl-alanine melting point: 109 C N-dodecanoyl-valine melting point: 107 C N-tetradecanoyl-valine melting point: 980C N-octadecanoyl-valine melting point: 930C N-dodecanoyl-leucine melting point: 109 ° C N-tetradecanoyl-leucine melting point: 102 C N-hexadecanoyl-leucine melting point: 88-890C N-octadecanoyl-leucine Melting point: 960C N-docosanoyl-leucine melting point: 980C N -hexadecanoyl-sarcosine melting point: 65-660C N-octanoyl-glycine melting point: 109 C N-decanoyl-glycine melting point:
114 C N-hexadecanoyl -ss-alanine melting point: 117-1180C N-benzoyl-ss-alanine melting point: 103-105oC N -4-phenylbenzoyl-alanine melting point: 103-105 "C N -dodecanoyl-4-aminobutyric acid Melting point: 92-93 C N-octadecanoyl-4-aminobutyric acid Melting point: 100-1020C N-Benzoyl-4-aminobutyric acid Melting point: 88-890C N-4 -phenylbenzoyl-4-aminobutyric acid Melting point: 181 C N -Tetradecanoyl-sarcosine melting point: 51-520C N-octadecanoyl-sarcosine melting point: 71-720C N-dodecanoyl-alanine melting point: 104-105oC N-dodecanoyl-phenylalanine melting point:
100 ° C N-hexadecanoyl-phenylalanine melting point: 98-99 C N-octadecanoyl-glycine methyl ester melting point: 83-84 C N-octadecanoyl-glycine ethyl ester melting point: 82-83 C N-octadecanoyl-alanine methyl ester melting point: 76-770C N-Octadecanoyl-phenylalanine-isopropyl ester Melting point: 69-70 ° C
example 1
Cream with N-acetyl-glycine-hexadecyl ester Composition: N-acetyl-glycine hexadecyl ester 3.0 g Benzalkon A 0.1 g Cremophor 0 4.0 g glycerol monostearate 4.0 g Lanette 0 5.0 g Walrat 3.0 g Cetiol V 10.0g dist. Water ad 100.0 g
Manufacturing
Benzalkon is dissolved in 700C warm water (I). The active substance is suspended in the melt (70 ° C.) of Cremophor 0, glycerol monostearate, Lanette 0, Walrat Cetiol V (II). II is emulsified in I at 70 ° C., followed by cold stirring.
Example 2
Cream with N-octadecanoyl-glycine Composition: N-octadecanoyl-glycine 1.0 g Benzalkon A 0.1 g Cremophor 0 4.0 g glycerine monostearate 4.0 g Lanette 0 5.0 g Walrat 3.0 g Cetiol V 10, 0 g dist. Water to 100.0 g Production: analogous to Example 1.
Example 3
Ointment with N-benzoyl-glycine-hexadecyl ester Composition: N-benzoyl-glycine hexadecyl ester 3.0 g Cremophor 0 6.0 g Cremophor A solid 1.0 g wool fat 2.0 g paraffin oil 45.0 g vaseline ad 100.0 g
Manufacturing
Cremophor 0, Cremophor A solid, wool grease, paraffin oil and Vaseline are melted together at 700C and the active substance is suspended, followed by cold stirring.
Example 4
Gel with N-acetyl-glycine-hexadecyl ester Composition: N-acetyl-glycine hexadecyl ester 3.0 g Carbopol 940 0.6 g triethanolamine 0.6 g Cremophor EL 5.0 g isopropanol 30.0 g dist. Water ad 100.0 g
Manufacturing
The solution of the active ingredient, Cremophor EL and triethanolamine in isopropanol is stirred into the aqueous solution of Car bopol.
Example 5
Bath essence with N-acetyl-glycine-hexadecyl ester
Composition: N-acetyl glycine hexadecyl ester 5.0 g Texapon N 25 30.0 g Comperlan OD 5.0 g isopropanol 20.0 g ethereal oil 2.0 g dist. Water ad 100.0 g
Manufacturing
The solution of the active substance and the essential oil in isopropanol is stirred into the aqueous solution of Texapon N 25 and Comperlan OD.
Example 6
Hair tincture with N-tetradecanol glycine
Composition:
N-tetradecanoyl glycine 0.25 g isoadipate 0.2 g
Perfume oil 0.1 g
Isopropanol 50.0 g dist. Water ad 100.0 g
Manufacturing
The active substance, isoadipate and perfume oil is dissolved in isopropanol and then water is added with stirring.
Example 7
Dry spray with N-acetyl-glycine-hexadecyl ester Composition: N-acetyl-glycine hexadecyl ester 3.0 g Span 85 0.4 g Frigen 11 A 3.0 g Frigen 12/114 40:60 93.6 g
Manufacturing
The active ingredient, Span 85 and Frigen 11 are in one
Ball mill mixed. This mixture, which has been cooled to −150 ° C., is slowly introduced into the propellant gas mixture, which has been cooled to −40 to −50 ° C., and filled with stirring.
Example 8
Foam aerosol with N-benzoyl-glycine-hexadecyl ester Composition: N-benzoyl-glycine hexadecyl ester 3.0 g
Cremophor EL 1.0 g Tween 80 1.2 g Texapon N 25 0.8 g 94% ethanol 21.0 g distilled water. 57.0 g of Frigen 12/114 60:40 16.0 g
Manufacturing
The active substance is dissolved in ethanol (I). Cremophor
EL, Tween 80 and Texapon N 25 are dissolved in water (II). I is entered in II with stirring and the concentrate obtained is filled into cans. After closing with a
The propellant gas is injected into the valve.
Example 9
Cream with N-Benzoyl-glycine-hexadecyl ester Composition: N-Benzoyl-glycine-hexadecyl ester 3.0 g Benzalkon A 0.1 g Cremophor 0 4.0 g Glycerine monostearate 4.0 g Lanette 0 5.0 g Walrat 3.0 g Cetiol V 10.0 g vitamin A acetate 30,000 IU
Vitamin E Acetate 20 each.
least. Water to 100.0 g Production: analogous to Example 1
Example 10
Lotio with N-Octadecanoyl-glycine Composition: N-Octadecanoyl-glycine 3.0 g Span 40 3.0 g Cremophor 0 2.0 g Lanette 0 2.0 g Walrat 1.0 g Cetiol V 5.0 g Paraffin oil subl. 1.0 g Nipagin M 0.1 g dist. Water ad 100.0 g
Manufacturing
Span 40, Cremophor 0, Lanette 0, Walrat, Cetiol V and paraffin oil are melted at 700C and the active substance is dissolved in them. Distilled water is heated to 80 ° C. and nipagin is dissolved in it; after cooling to 70 ° C., the fat melt is introduced, homogenized and stirred until cold.
Example 11
Shampoo with N-acetyl-glycine-hexadecyl ester Composition: N-acetyl-glycine hexadecyl ester 3.0 g Zetesol SE 35 T 55.0 g Tylose MH 300 1.0 g Nipagin M 0.5 g dist. Water ad 100.0 g
Manufacturing
Distilled water is heated to 80 ° C., nipagin M is dissolved in it and tylose is suspended. The active substance is distributed in Zetesol and perfume oil using a high-speed mixer, added to the Tylose slime, homogenized and deaerated.
Example 12
Powder with N-acetyl-glycine-hexadecyl ester Composition: N-acetyl-glycine hexadecyl ester 3.0 g Aerosil 1.0 g magnesium stearate 0.2 g ANM corn starch ad 100.0 g
Manufacturing
Active ingredients, Aerosil and magnesium stearate are added one after the other to 1/3 of the corn starch and mixed well. Then the remaining amount of corn starch is added and mixed well again.
Example 13
Paste with N- (4'-phenylbenzoyl) -4-aminobutyric acid Composition: N- (4'-phenylbenzoyl) -4-aminobutyric acid 3.0 g Lanogen 1500 20.0 g isopropanol 45.0 g Veegum pharm. 10.0 g pigment and dye 1.0 g perfume oil 0.2 g dist. Water ad 100.0 g
Production The active substance is dissolved in Lanogen at 600C (I). Perfume oil is dissolved in isopropanol (II). Distilled water is heated to 60 ° C., Veegum is distributed in it and left to swell.
For this you add II and I, it is kneaded and homogenized.
Example 14
Tincture with N-Benzoyl-glycine-hexadecyl ester Composition: N-Benzoyl-glycine hexadecyl ester 3.0 g isopropanol 25, Og ethanol 95% pure 25.0 g perfume oil 0.2 g dist. Water ad 100.0 g
Manufacturing
Isopropanol and ethanol are heated to 600C and perfume oil and the active substance are dissolved in them. Then water is added, the mixture is cooled and filtered.
In the same way, all of the compounds of the formula I can be incorporated into the usual preparation forms.
The scope of protection of the patent is limited by Art. 1, No. 2. PatG.
Claims (1)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2234399A DE2234399A1 (en) | 1972-07-17 | 1972-07-17 | SKIN PROTECTION PRODUCTS |
| AT608773A AT338434B (en) | 1972-07-17 | 1973-07-11 | COSMETIC SKIN CARE PRODUCTS |
| JP48079223A JPS4985244A (en) | 1972-07-17 | 1973-07-13 | |
| DK392873A DK133537C (en) | 1972-07-17 | 1973-07-16 | MEDIUM FOR COSMETIC SKIN CARE |
| CA176,467A CA1022849A (en) | 1972-07-17 | 1973-07-16 | Dermatological compositions comprising acylamino-carboxylic acid derivatives |
| CH1034873A CH600873A5 (en) | 1972-07-17 | 1973-07-16 | Acylaminocarboxylic acid compsns |
| AU58129/73A AU483797B2 (en) | 1972-07-17 | 1973-07-16 | Dermatological compositions |
| GB3369973A GB1436614A (en) | 1972-07-17 | 1973-07-16 | Dermatological compositions |
| DD172459A DD107591A5 (en) | 1972-07-17 | 1973-07-16 | |
| BE133542A BE802414A (en) | 1972-07-17 | 1973-07-16 | SKIN PROTECTION PRODUCTS |
| NL7309851A NL7309851A (en) | 1972-07-17 | 1973-07-16 | |
| FR7326126A FR2192795B1 (en) | 1972-07-17 | 1973-07-17 | |
| US05/596,852 US4016287A (en) | 1972-07-17 | 1975-07-17 | Dermatological compositions containing an acylamino-carboxylic acid or an alkyl ester thereof |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2234399A DE2234399A1 (en) | 1972-07-17 | 1972-07-17 | SKIN PROTECTION PRODUCTS |
| US37975173A | 1973-07-16 | 1973-07-16 | |
| GB3369973A GB1436614A (en) | 1972-07-17 | 1973-07-16 | Dermatological compositions |
| CH1034873A CH600873A5 (en) | 1972-07-17 | 1973-07-16 | Acylaminocarboxylic acid compsns |
| FR7326126A FR2192795B1 (en) | 1972-07-17 | 1973-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH600873A5 true CH600873A5 (en) | 1978-06-30 |
Family
ID=27509394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1034873A CH600873A5 (en) | 1972-07-17 | 1973-07-16 | Acylaminocarboxylic acid compsns |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS4985244A (en) |
| AT (1) | AT338434B (en) |
| AU (1) | AU483797B2 (en) |
| BE (1) | BE802414A (en) |
| CA (1) | CA1022849A (en) |
| CH (1) | CH600873A5 (en) |
| DD (1) | DD107591A5 (en) |
| DE (1) | DE2234399A1 (en) |
| DK (1) | DK133537C (en) |
| FR (1) | FR2192795B1 (en) |
| GB (1) | GB1436614A (en) |
| NL (1) | NL7309851A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998009611A1 (en) * | 1996-09-09 | 1998-03-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques - Seppic | Cosmetic use of compounds with lipoaminoacid structure and cosmetic compositions with soothing activity incorporating some of these compounds |
| FR2753096A1 (en) * | 1996-09-09 | 1998-03-13 | Seppic Sa | N-Lauroyl-aminoacid cosmetic soothing agent |
| DE19926527A1 (en) * | 1999-06-10 | 2000-12-14 | Goldwell Gmbh | Aqueous detergent mixture comprises anionic surfactant forming the majority of the total surfactant content, 8-22C acyl aminocarboxylic acid (salt) and glycerin mono-10-18C-fatty acid ester |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147782A (en) * | 1976-06-24 | 1979-04-03 | William H. Rorer, Inc. | Pharmaceutical detergent composition |
| DE2851831A1 (en) * | 1978-11-30 | 1980-06-19 | Henkel Kgaa | HAIR TREATMENT WITH ANTI-DUPLIC EFFECT |
| JPS5872512A (en) * | 1981-10-26 | 1983-04-30 | Miyoshi Kasei:Kk | Make-up cosmetic |
| FI832935A7 (en) * | 1982-08-20 | 1984-02-21 | Midit | DERIVAT AV W-AMINOSYROR, DERAS FRAMSTAELLNING SAMT DESSA DERIVAT INNEHAOLLANDE BLANDNINGAR |
| DE3233638A1 (en) * | 1982-09-10 | 1984-03-15 | Thilo & Co Gmbh Dr | DERMATOLOGICAL PREPARATION |
| US4551279A (en) * | 1984-01-09 | 1985-11-05 | G. D. Searle & Co. | Protease inhibitors |
| GB8520714D0 (en) * | 1985-08-19 | 1985-09-25 | Secr Defence | Amino acid derivatives |
| IL79624A0 (en) * | 1986-08-05 | 1986-11-30 | Yeda Res & Dev | Amphiphilic amides and films produced from these |
| US4749563A (en) * | 1986-12-08 | 1988-06-07 | Charles Of The Ritz Group Ltd. | Moisture-resistant skin treatment compositions |
| EP0310299A1 (en) * | 1987-09-28 | 1989-04-05 | The Procter & Gamble Company | Beta-amino acid ester derivatives of alcoholic actives having extended duration of activity |
| FR2649697A1 (en) * | 1989-07-11 | 1991-01-18 | Oreal | NOVEL URETHANNE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN PARTICULAR AS MOISTURIZING AGENTS IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DRY SKINS |
| GB8918709D0 (en) * | 1989-08-16 | 1989-09-27 | Unilever Plc | Cosmetic composition |
| GB8918708D0 (en) * | 1989-08-16 | 1989-09-27 | Unilever Plc | Cosmetic composition |
| FR2658190B1 (en) * | 1990-02-15 | 1992-06-05 | Panmedica Sa | HYDROQUINONE AMINO ACID ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM. |
| FR2668927B1 (en) * | 1990-11-09 | 1993-01-08 | Oreal | COSMETIC ANHYDROUS COMPOSITION IN AEROSOL FORM FOR THE FORMATION OF A FOAM. |
| IL101708A (en) * | 1992-04-28 | 1996-08-04 | Senyorina Ltd | Anti-fattening drugs comprising amino acid derivatives |
| FR2702959B1 (en) * | 1993-03-25 | 1995-06-16 | Thorel Jean Noel | NEW COSMETIC OR PHARMACEUTICAL PREPARATIONS, FOR TOPICAL USE. |
| DE69427765T2 (en) * | 1993-09-20 | 2002-05-23 | Waters Corp., Milford | CHIRAL SURFACES AND METHOD FOR USE IN CHIRAL SEPARATIONS |
| FR2742990B1 (en) * | 1995-12-28 | 1998-03-27 | Fabre Pierre Dermo Cosmetique | ANTIBACTERIAL COMPOSITION BASED ON ACYLGLYCIN AND ZINC SALT |
| JPH10130128A (en) * | 1996-10-29 | 1998-05-19 | Kashima Sekiyu Kk | Cosmetics |
| FR2766366B1 (en) * | 1997-07-24 | 2000-02-11 | Seppic Sa | USE OF AT LEAST ONE LIPOAMINOACID AS AN ANTAGONIST OF THE SUBSTANCE P IN A COSMETIC FORMULATION FOR SOOTHING AND / OR PROTECTING ALL SKIN TYPES AND, IN PARTICULAR, SENSITIVE SKIN |
| EP1024134A4 (en) * | 1997-10-09 | 2003-05-14 | Ono Pharmaceutical Co | Aminobutanoic acid derivatives |
| TWI225793B (en) | 1997-12-25 | 2005-01-01 | Ajinomoto Kk | Cosmetic composition |
| EP1676832A3 (en) * | 1998-08-07 | 2006-09-06 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| FR2787323B1 (en) | 1998-12-22 | 2003-02-14 | Seppic Sa | USE OF N-ACYLATED AMINO ACID COMPOUNDS AS TEXTURING AGENT |
| DE60212474T2 (en) * | 2001-03-14 | 2007-03-01 | Johnson & Johnson Gmbh | Use of alkyl 3- (N-alkylacetamino) propionate derivatives as humectants |
| DE10221813A1 (en) * | 2002-05-16 | 2003-11-27 | Beiersdorf Ag | High-foaming aqueous cosmetic cleansing gel for use on facial and body skin contains a thickener and an acylamino acid surfactant |
| CA2501318A1 (en) | 2002-10-10 | 2004-04-22 | Yeda Research And Development Co. Ltd | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| JP2005239625A (en) * | 2004-02-26 | 2005-09-08 | Kanebo Cosmetics Inc | Hair cosmetics |
| JP4865251B2 (en) * | 2005-05-09 | 2012-02-01 | 株式会社 資生堂 | Deficiency keratinization inhibitor, pore reducing agent, and composition for external use on skin |
| JPWO2007013662A1 (en) * | 2005-07-26 | 2009-02-12 | 株式会社資生堂 | Anti-wrinkle / improving agent |
| WO2007034750A1 (en) * | 2005-09-22 | 2007-03-29 | Shiseido Company, Ltd. | Wrinkle-improving agent |
| DK3026044T3 (en) * | 2006-06-26 | 2019-02-18 | Akebia Therapeutics Inc | PROLYL HYDROXYLASE INHIBITORS AND METHODS FOR USE |
| US7511162B2 (en) | 2007-02-20 | 2009-03-31 | Multi Formulations Ltd. | Preparation of amino acid-fatty acid anhydrides |
| US7319157B1 (en) * | 2007-02-20 | 2008-01-15 | Multi Formulations Ltd. | Creatine-fatty acids |
| US7314945B1 (en) | 2007-02-20 | 2008-01-01 | Multi Formulations Ltd. | Creatine-fatty acids |
| EP2123253B1 (en) * | 2007-03-16 | 2017-06-28 | Shiseido Company, Ltd. | Wrinkling-preventing and -alleviating agent |
| FR2923383B1 (en) * | 2007-11-08 | 2010-03-19 | Oreal | USE OF AN N-ACYLATED SARCOSINATE AS A MICROBIAL ANTI-ADHESION AGENT. |
| FR2935378B1 (en) * | 2008-08-29 | 2015-03-27 | Seppic Sa | USE OF N-ACYL AMINOACIDS AS ACTIVE COSMETIC AND PHARMACEUTICAL PRINCIPLES, CAPABLE OF REDUCING THE INFLAMMATORY CONDITION OF SENESCENT REPLICATIVE FIBROBLASTS FROM HUMAN ADULT DERMAS; ANTI-AGE COSMETIC COMPOSITIONS |
| FR2935379B1 (en) * | 2008-09-03 | 2012-08-31 | Seppic Sa | USE OF N-ACYL AMINO ACIDS AS A COSMETIC AND PHARMACEUTICAL ACTIVE INGREDIENT, REGULATORS OF THE PROPORTION OF BASIC KERATINOCYTES OF THE HUMAN SKIN EPIDERM EXPRESSING THE NUCLEAR FORM OF SURVIVIN; Compositions |
| JP2010090113A (en) * | 2008-09-11 | 2010-04-22 | Shiseido Co Ltd | Skin cosmetic |
| JP5207901B2 (en) * | 2008-09-26 | 2013-06-12 | 株式会社 資生堂 | Skin cosmetics |
| FR2948564B1 (en) | 2009-07-28 | 2012-03-30 | Seppic Sa | USE OF N-HEXADECANOYL ISOLEUCINE FOR REGULATING THE ACTIVITY OF CELLS PRESENT IN ADIPOSE TISSUE OF HUMAN SKIN HYPODERM |
| FR2968952A1 (en) * | 2010-12-17 | 2012-06-22 | Oreal | N-ACYL AMINO ACID ESTER AS A SOOTHING AGENT |
| JP6009147B2 (en) * | 2011-03-15 | 2016-10-19 | 株式会社 資生堂 | Bleomycin hydrolase production promoter |
| JP5254417B2 (en) * | 2011-10-07 | 2013-08-07 | 株式会社 資生堂 | Inadequate keratinization inhibitor, pore reducing agent, and rough skin prevention / improving agent |
| FR2988599B1 (en) * | 2012-03-30 | 2016-12-09 | Oreal | USE OF A N-ACYL AMINO ACID ESTER FOR MATIFYING THE SKIN |
| KR102045589B1 (en) | 2012-03-30 | 2019-11-15 | 지보당 에스아 | N-acyl-amino acid derivatives as food flavouring compounds |
| US10645955B2 (en) | 2012-03-30 | 2020-05-12 | Givaudan Sa | N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds |
| WO2013149019A1 (en) | 2012-03-30 | 2013-10-03 | Givaudan S.A. | N-acylated methionine derivatives as food flavouring compounds |
| EP2830438B1 (en) * | 2012-03-30 | 2019-09-04 | Givaudan SA | N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds, powder compositions containing them |
| BR112014024157B1 (en) | 2012-03-30 | 2020-12-15 | Givaudan Sa | EDIBLE COMPOSITION, STOCK SOLUTION AND METHOD TO COMPLEMENT THE TASTE OR TASTE OF EDIBLE PRODUCTS CHARACTERISTICS |
| JP6224072B2 (en) | 2012-03-30 | 2017-11-01 | ジボダン エス エー | N-acyl-amino acid derivatives for improving flavor profile edible compositions |
| BR112014024323B1 (en) | 2012-03-30 | 2020-03-10 | Givaudan Sa | COMPOSITIONS UNDERSTANDING N-ACYLATED CARBOXYLIC 1-AMINOCYCLEALKYL ACIDS, STANDARD SOLUTION AND USE |
| WO2015050535A1 (en) | 2013-10-02 | 2015-04-09 | Givaudan S.A. | Organic compounds |
| US10834943B2 (en) | 2013-10-02 | 2020-11-17 | Givaudan S.A. | Organic compounds having taste-modifying properties |
| EP3052472B1 (en) | 2013-10-02 | 2019-02-27 | Givaudan S.A. | N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them |
| US10834950B2 (en) | 2013-10-02 | 2020-11-17 | Givaudan S.A. | Organic compounds |
| EP3057448B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan S.A. | Organic compounds having taste-modifying properties |
| EP3057446B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan S.A. | Organic compounds having taste-modifying properties |
| EP3057444B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan SA | Organic compounds having taste-modifying properties |
| GB201317424D0 (en) | 2013-10-02 | 2013-11-13 | Givaudan Sa | Improvements in or relating to organic compounds |
| KR102782702B1 (en) * | 2018-06-04 | 2025-03-18 | 쑤저우 아우릿 바이오팜 컴퍼니 리미티드 | Amino acid self-assembled supramolecular polymers and their preparation and applications |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR787819A (en) * | 1934-03-24 | 1935-09-30 | Ig Farbenindustrie Ag | New washing and cleaning agents |
| BE569111A (en) * | 1957-07-05 | |||
| DE1617640C3 (en) * | 1967-06-15 | 1980-11-13 | Merz & Co, 6000 Frankfurt | Mixture for the production of cosmetic face masks |
-
1972
- 1972-07-17 DE DE2234399A patent/DE2234399A1/en not_active Withdrawn
-
1973
- 1973-07-11 AT AT608773A patent/AT338434B/en not_active IP Right Cessation
- 1973-07-13 JP JP48079223A patent/JPS4985244A/ja active Pending
- 1973-07-16 DD DD172459A patent/DD107591A5/xx unknown
- 1973-07-16 GB GB3369973A patent/GB1436614A/en not_active Expired
- 1973-07-16 NL NL7309851A patent/NL7309851A/xx not_active Application Discontinuation
- 1973-07-16 CA CA176,467A patent/CA1022849A/en not_active Expired
- 1973-07-16 CH CH1034873A patent/CH600873A5/en not_active IP Right Cessation
- 1973-07-16 DK DK392873A patent/DK133537C/en active
- 1973-07-16 BE BE133542A patent/BE802414A/en unknown
- 1973-07-16 AU AU58129/73A patent/AU483797B2/en not_active Expired
- 1973-07-17 FR FR7326126A patent/FR2192795B1/fr not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998009611A1 (en) * | 1996-09-09 | 1998-03-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques - Seppic | Cosmetic use of compounds with lipoaminoacid structure and cosmetic compositions with soothing activity incorporating some of these compounds |
| FR2753096A1 (en) * | 1996-09-09 | 1998-03-13 | Seppic Sa | N-Lauroyl-aminoacid cosmetic soothing agent |
| DE19926527A1 (en) * | 1999-06-10 | 2000-12-14 | Goldwell Gmbh | Aqueous detergent mixture comprises anionic surfactant forming the majority of the total surfactant content, 8-22C acyl aminocarboxylic acid (salt) and glycerin mono-10-18C-fatty acid ester |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1436614A (en) | 1976-05-19 |
| DD107591A5 (en) | 1974-08-12 |
| DK133537C (en) | 1976-10-25 |
| AU483797B2 (en) | 1975-01-16 |
| DK133537B (en) | 1976-06-08 |
| DE2234399A1 (en) | 1974-01-31 |
| JPS4985244A (en) | 1974-08-15 |
| AT338434B (en) | 1977-08-25 |
| ATA608773A (en) | 1976-05-15 |
| CA1022849A (en) | 1977-12-20 |
| NL7309851A (en) | 1974-01-21 |
| FR2192795B1 (en) | 1977-05-13 |
| AU5812973A (en) | 1975-01-16 |
| BE802414A (en) | 1974-01-16 |
| FR2192795A1 (en) | 1974-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH600873A5 (en) | Acylaminocarboxylic acid compsns | |
| DE69611754T2 (en) | HYDROCHAL CONDIVATIVES, CONTAINING COSMETIC COMPOSITIONS, AND METHOD FOR THE PRODUCTION OF BOTH | |
| DE2322232A1 (en) | NEW ACYLAMINO ACID AMIDES | |
| DE2102172C3 (en) | New means of treating and caring for the skin | |
| DE2616479C2 (en) | Substituted fluoroacylresorcinols, processes for their preparation and pharmaceuticals and cosmetics containing them | |
| DE68904529T2 (en) | DERIVATIVES OF 5-BENZYLIDES-3-OXACYCLOPENTANONE, THEIR PRODUCTION PROCESS AND THEIR USE IN COSMETIC COMPOSITIONS TO PROTECT THE SKIN AND HAIR FROM SUN RADIATION. | |
| DE69010047T2 (en) | Cosmetic and pharmaceutical compositions containing hydrophilic derivatives of benzylidene camphor and sulfonated hydrophilic derivatives of benzylidene camphor. | |
| EP0012178B1 (en) | Benzoxazol derivatives, methods for their preparation, cosmetic compositions containing such compounds, use of such compounds as uv-a filters and method of protecting the skin and hair and method of stabilizing cosmetic compositions | |
| DE3415413A1 (en) | MELANINE INHIBITOR | |
| DE69001515T2 (en) | URETHANE DERIVATIVES, THEIR PRODUCTION AND USE AS A SKIN-MOISTURING AGENT IN COSMETIC AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DRY SKIN. | |
| EP0081771B1 (en) | Heterocyclic compounds, their preparation, cosmetic preparations containing them and their use in hair and skin care | |
| DE69103648T2 (en) | Lactic acid acylates, their salts, their manufacturing process and compositions containing them. | |
| DE2827658C3 (en) | Chalk of dye for human hair | |
| DE69500082T2 (en) | Photochemically cleavable agent capable of chelating metals and preparations containing them | |
| AT403655B (en) | USE OF GLYCOPROTEINS FROM GRAM-NEGATIVE BACTERIA IN A METHOD FOR THE PRODUCTION OF COSMETIC OR DERMATOLOGICAL COMPOSITIONS PROMOTING HAIR GROWTH, AND SUCH COMPOSITIONS | |
| EP0166155A1 (en) | 2-Alkylsulphonyl-1,4-diaminobenzenes, process for their preparation and oxidative hair-dyeing compositions containing these compounds | |
| DE2105672A1 (en) | ||
| DE2924229A1 (en) | COSMETIC PREPARATIONS FOR THE TREATMENT OF OIL HAIR AND OIL SKIN, SUITABLE ACTIVE SUBSTANCE COMPOUNDS AND METHOD FOR THEIR PRODUCTION | |
| DE4033563A1 (en) | New use of furoic and thiophenic acid derivs. - as anti-seborrhoeic agents in prodn. of prepn(s) for treatment of acne, dandruff, etc. | |
| EP0101918A1 (en) | Use of arylketobutenoic-acid derivatives, as component in cosmetic agents as well as arylketobutenoic-acid derivatives | |
| EP0079899B1 (en) | Topical cosmetic preparations containing hetero-aryl-mercapto-alkanoic acid derivatives as additives having an anti-seborrhea acitivity | |
| DE2456634A1 (en) | Pyroglutamic acid aralkyl esters - prepd e.g. by esterifying pyroglutamic acid with an aralkanol | |
| DE1617705C3 (en) | Cosmetic product for hair treatment | |
| DE955093C (en) | Hair and skin care products | |
| WO1984003699A1 (en) | 3-amino-tetrahydro-1,3-thiazine-2,4-dione, utilisation thereof and skin treatment product containing said compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |